Clinical trials
Active, not recruiting Hematologic Neoplasms trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
119 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2010 | 1 |
| 2012 | 1 |
| 2013 | 2 |
| 2014 | 3 |
| 2015 | 9 |
| 2016 | 14 |
| 2017 | 8 |
| 2018 | 6 |
| 2019 | 8 |
| 2020 | 19 |
| 2021 | 10 |
| 2022 | 16 |
| 2023 | 7 |
| 2024 | 11 |
| 2025 | 2 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 119 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| M.D. Anderson Cancer Center | 23 |
| National Cancer Institute (NCI) | 21 |
| City of Hope Medical Center | 11 |
| Fred Hutchinson Cancer Center | 4 |
| Bellicum Pharmaceuticals | 3 |
| Janssen Research & Development, LLC | 3 |
| Mount Sinai Hospital, Canada | 3 |
| University of Rochester NCORP Research Base | 3 |
| Children's Oncology Group | 2 |
| Memorial Sloan Kettering Cancer Center | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hematologic Neoplasms | 119 |
| Lymphoma | 24 |
| Multiple Myeloma | 23 |
| Leukemia, Myeloid, Acute | 13 |
| Myelodysplastic Syndromes | 13 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 9 |
| Leukemia | 8 |
| Lymphoma, Non-Hodgkin | 8 |
| Neoplasms | 7 |
| COVID-19 | 6 |
Trials
Showing 76 to 100 of 119. Each trial links to its page on Pharma Observatory.
19 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.